Stuart A. Scott
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 62
- Inflammatory mediators and NSAID effects 11
-
- Pharmaceutical studies and practices 20
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 62
- Inflammatory mediators and NSAID effects 11
- Statistics and Probability top 0.5%
-
- Antiplatelet Therapy and Cardiovascular Diseases 18
-
- Genomics and Rare Diseases 27
- Genomic variations and chromosomal abnormalities 16
-
- Drug Transport and Resistance Mechanisms 13
-
- Diabetes Treatment and Management 10
- Co-authors
- Teri E. KleinKatrin SangkuhlJean‐Sébastien HulotRobert J. DesnickMichelle Whirl‐CarrilloAndrea GaedigkVictoria M. PrattCatherine M. Stein
- Journals
- Clinical Pharmacology & Therapeutics (25 papers)Journal of Molecular Diagnostics (14 papers)Pharmacogenomics (8 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Stuart A. Scott
138 papers receiving 8.6k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Pharmacology 4.3k
- Pediatrics, Perinatology and Child Health 1.7k
- Pharmacology 1.2k
- Statistics and Probability 541
- Cardiology and Cardiovascular Medicine 1.4k
Countries citing papers authored by Stuart A. Scott
This map shows the geographic impact of Stuart A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart A. Scott more than expected).
Fields of papers citing papers by Stuart A. Scott
This network shows the impact of papers produced by Stuart A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart A. Scott. The network helps show where Stuart A. Scott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stuart A. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 21 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 22 | |
| 6 | 2023 | 33 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 97 | |
| 9 | 2020 | 11 | |
| 10 | Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists | 2019 | 12 |
| 11 | 2018 | 141 | |
| 12 | 2018 | 40 | |
| 13 | 2018 | 6 | |
| 14 | 2016 | 90 | |
| 15 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors | 2015 | 51 |
| 16 | 2014 | 11 | |
| 17 | 2012 | 34 | |
| 18 | 2012 | 20 | |
| 19 | 2012 | 1 | |
| 20 | 2011 | 145 |
About Stuart A. Scott
Stuart A. Scott is a scholar working on Pharmacology, Genetics, Pediatrics, Perinatology and Child Health, Statistics and Probability and Endocrinology, Diabetes and Metabolism, having authored 141 papers that have together received 8.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (62 papers), Genomics and Rare Diseases (27 papers), Pharmaceutical studies and practices (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Genomic variations and chromosomal abnormalities (16 papers), Drug Transport and Resistance Mechanisms (13 papers), Inflammatory mediators and NSAID effects (11 papers) and Diabetes Treatment and Management (10 papers). The work is most often cited by research in Pharmacology (4.3k citations), Pediatrics, Perinatology and Child Health (1.7k citations), Pharmacology (1.2k citations), Statistics and Probability (541 citations) and Cardiology and Cardiovascular Medicine (1.4k citations). Stuart A. Scott has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Teri E. Klein, Katrin Sangkuhl, Jean‐Sébastien Hulot, Robert J. Desnick, Michelle Whirl‐Carrillo, Andrea Gaedigk, Victoria M. Pratt, Catherine M. Stein, Ruth Kornreich and Munir Pirmohamed. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Molecular Diagnostics, Pharmacogenomics, Clinical and Translational Science and Genetics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.